Summary by Futu AI
FOXO Technologies Inc. (FOXO) announced the filing of a PRE 14A preliminary proxy statement with the SEC, indicating an upcoming annual meeting of stockholders. The meeting is set to take place virtually on a yet-to-be-determined date in 2024. The agenda includes several key proposals, such as a reverse stock split, issuance of shares in connection with various agreements, and the election of directors. Notably, the reverse stock split aims to boost the market price of FOXO's stock to comply with NYSE American listing standards. Other proposals involve approving share issuances related to exchange agreements with Smithline and ClearThink, stock exchange agreements with Myrtle and Rennova Health, Inc. (RHI), and securities purchase agreements for senior notes. Additionally, the meeting will address the potential appointment of a majority of directors by RHI, which could result in a change of control. The board recommends votes in favor of all proposals, including the ratification of Kreit & Chiu CPA LLP as the independent auditor for 2024.